Global X Genomics & Biotechnology ETF
GNOM
58 hedge funds and large institutions have $134M invested in Global X Genomics & Biotechnology ETF in 2022 Q3 according to their latest regulatory filings, with 7 funds opening new positions, 19 increasing their positions, 15 reducing their positions, and 7 closing their positions.
27% more repeat investments, than reductions
Existing positions increased: 19 | Existing positions reduced: 15
21% more capital invested
Capital invested by funds: $111M → $134M (+$22.9M)
0.51% more ownership
Funds ownership: 15.76% → 16.27% (+0.51%)
0% more funds holding
Funds holding: 58 → 58 (0)
0% more first-time investments, than exits
New positions opened: 7 | Existing positions closed: 7
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Northwestern Mutual Wealth Management
Milwaukee,
Wisconsin
|
+$29.9M |
| 2 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$2.22M |
| 3 |
Nomura Asset Management
Tokyo,
Japan
|
+$701K |
| 4 |
PAG
Private Advisor Group
Morristown,
New Jersey
|
+$411K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$366K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PNC Financial Services Group
Pittsburgh,
Pennsylvania
|
-$11.1M |
| 2 |
Mirae Asset Global Investments
Seoul,
South Korea
|
-$858K |
| 3 |
UBS Group
Zurich,
Switzerland
|
-$345K |
| 4 |
BS
Banco Santander
Madrid,
Spain
|
-$223K |
| 5 |
AWE
Avidian Wealth Enterprises
Houston,
Texas
|
-$150K |
GNOM Hedge Fund Activity: Q3 2022 in Review
58 of the 5,805 institutional investors tracked by Wall St. Rank reported a position in Global X Genomics & Biotechnology ETF (GNOM) for Q3 2022, worth a combined $134M — up 21% from $111M a quarter earlier.
Fund positioning in GNOM was balanced in Q3 2022: 7 funds opened new positions, 7 closed out, 19 added to existing stakes and 15 trimmed.
The largest buyer was Northwestern Mutual Wealth Management, adding an estimated $29.9M. The largest seller was PNC Financial Services Group, cutting an estimated $11.1M.
- 58 institutional investors held Global X Genomics & Biotechnology ETF (GNOM) as of Q3 2022, unchanged from Q2 2022.
- Funds reported $134M of Global X Genomics & Biotechnology ETF stock for Q3 2022, up 21% quarter-over-quarter.
- 7 funds opened new Global X Genomics & Biotechnology ETF positions in Q3 2022 and 7 closed out, a net change of 0 holders.
- The largest Global X Genomics & Biotechnology ETF buyer in Q3 2022 was Northwestern Mutual Wealth Management, an estimated $29.9M added.
- The largest Global X Genomics & Biotechnology ETF seller in Q3 2022 was PNC Financial Services Group, an estimated $11.1M sold.
Based on aggregated 13F filings for Q3 2022.